CIK 1906594
China Universal Asset Management Co., Ltd.
Institutional 13F holdings & portfolio
Holdings
497
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
4
Holdings
13F filings as of Dec 31, 2025 · Showing 251–300 of 497
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| VCYT | VERACYTE INC | 13K | $500K+ | SH |
| EYPT | EYEPOINT INC | 29K | $500K+ | SH |
| AXP | AMERICAN EXPRESS CO | 1K | $500K+ | SH |
| DIS | WALT DISNEY CO/THE | 5K | $500K+ | SH |
| VERA | VERA THERAPEUTICS INC | 10K | $500K+ | SH |
| IMCR | IMMUNOCORE HOLDINGS PLC-ADR | 15K | $500K+ | SH |
| APLS | APELLIS PHARMACEUTICALS INC | 21K | $500K+ | SH |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 10K | $500K+ | SH |
| IDYA | IDEAYA BIOSCIENCES INC | 14K | $100K–$500K | SH |
| ZBIO | ZENAS BIOPHARMA INC | 13K | $100K–$500K | SH |
| MBX | MBX BIOSCIENCES INC | 15K | $100K–$500K | SH |
| MDT | MEDTRONIC PLC | 5K | $100K–$500K | SH |
| MAZE | MAZE THERAPEUTICS INC | 11K | $100K–$500K | SH |
| MLYS | MINERALYS THERAPEUTICS INC | 13K | $100K–$500K | SH |
| BEAM | BEAM THERAPEUTICS INC | 17K | $100K–$500K | SH |
| DYN | DYNE THERAPEUTICS INC | 23K | $100K–$500K | SH |
| VFC | VF CORP | 25K | $100K–$500K | SH |
| HSAI | HESAI GROUP | 20K | $100K–$500K | SH |
| ZETA | ZETA GLOBAL HOLDINGS CORP-A | 22K | $100K–$500K | SH |
| OCUL | OCULAR THERAPEUTIX INC | 36K | $100K–$500K | SH |
| AS | AMER SPORTS INC | 12K | $100K–$500K | SH |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 26K | $100K–$500K | SH |
| EWTX | EDGEWISE THERAPEUTICS INC | 17K | $100K–$500K | SH |
| ARM | ARM HOLDINGS PLC-ADR | 4K | $100K–$500K | SH |
| SION | SIONNA THERAPEUTICS INC | 10K | $100K–$500K | SH |
| SYRE | SPYRE THERAPEUTICS INC | 13K | $100K–$500K | SH |
| HUM | HUMANA INC | 2K | $100K–$500K | SH |
| STOK | STOKE THERAPEUTICS INC | 13K | $100K–$500K | SH |
| DECK | DECKERS OUTDOOR CORP | 4K | $100K–$500K | SH |
| DNLI | DENALI THERAPEUTICS INC | 24K | $100K–$500K | SH |
| CNTA | CENTESSA PHARMACEUTICALS-ADR | 16K | $100K–$500K | SH |
| NIO | NIO INC - ADR | 75K | $100K–$500K | SH |
| SRPT | SAREPTA THERAPEUTICS INC | 17K | $100K–$500K | SH |
| NTRA | NATERA INC | 2K | $100K–$500K | SH |
| ANAB | ANAPTYSBIO INC | 8K | $100K–$500K | SH |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 16K | $100K–$500K | SH |
| HRMY | HARMONY BIOSCIENCES HOLDINGS | 9K | $100K–$500K | SH |
| WRD | WERIDE INC-ADR | 40K | $100K–$500K | SH |
| RXRX | RECURSION PHARMACEUTICALS-A | 84K | $100K–$500K | SH |
| AUPH | AURINIA PHARMACEUTICALS INC | 21K | $100K–$500K | SH |
| A | AGILENT TECHNOLOGIES INC | 3K | $100K–$500K | SH |
| AZO | AUTOZONE INC | 100 | $100K–$500K | SH |
| RAPP | RAPPORT THERAPEUTICS INC | 11K | $100K–$500K | SH |
| OLMA | OLEMA PHARMACEUTICALS INC | 13K | $100K–$500K | SH |
| DSGN | DESIGN THERAPEUTICS INC | 34K | $100K–$500K | SH |
| ZYME | ZYMEWORKS INC | 12K | $100K–$500K | SH |
| IBRX | IMMUNITYBIO INC | 161K | $100K–$500K | SH |
| TWST | TWIST BIOSCIENCE CORP | 10K | $100K–$500K | SH |
| NRIX | NURIX THERAPEUTICS INC | 17K | $100K–$500K | SH |
| TXG | 10X GENOMICS INC-CLASS A | 19K | $100K–$500K | SH |